Trial Profile
A Phase 3 Investigator-blinded, Randomized, Placebo and Active Parallel Group, non-inferiority, Multicenter study of M512101 in Japanese Patients with Acne Vulgaris
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 May 2016
Price :
$35
*
At a glance
- Drugs Ozenoxacin (Primary) ; Nadifloxacin
- Indications Acne vulgaris
- Focus Therapeutic Use
- Sponsors Maruho
- 04 Dec 2015 New trial record